A Phase 3, Randomized Study Of SU011248 Versus Interferon-Alfa As First-Line Systemic Therapy For Patients With Metastatic Renal Cell Carcinoma
收藏DataCite Commons2025-06-01 更新2024-07-13 收录
下载链接：
https://search.vivli.org/doiLanding/studies/00005068/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
The purpose of this study is to test whether SU011248 has activity and is safe compared to interferon-alfa as first-line therapy in patients with metastatic renal cell carcinoma (RCC).
提供机构：
Vivli
创建时间：
2019-11-27
